Industry insiders continue to spar over Waxman-Hatch Act

Antonio Ciaccia, President of 3 Axis Advisors, led a discussion on pharmacy benefit manager reform and how the inability to pass legislation has led to increased financial hardships in community pharmacy.

Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.

A survey conducted by 3 Axis Advisors revealed potential impacts of the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.

This special Over the Counter episode, brought to you by Total Pharmacy® and Omega Pharmacy Group, dives into how to navigate the business of independent pharmacy and get ahead of key policy changes.

The Federal Trade Commission released its second interim staff report on industry-leading pharmacy benefit managers and their practices specifically regarding specialty drugs.

Ahead of its first general meeting in 2025, lawmakers called on the FTC to vote “yes” on releasing a second interim staff report on PBMs.